BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24122234)

  • 21. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
    Cheung LW; Leung PC; Wong AS
    Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 12-O-tetradecanoylphorbol-13-acetate-induced invasion/migration of glioblastoma cells through activating PKCalpha/ERK/NF-kappaB-dependent MMP-9 expression.
    Lin CW; Shen SC; Chien CC; Yang LY; Shia LT; Chen YC
    J Cell Physiol; 2010 Nov; 225(2):472-81. PubMed ID: 20458747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Wnt-5A in interleukin-1beta-induced matrix metalloproteinase expression in rabbit temporomandibular joint condylar chondrocytes.
    Ge X; Ma X; Meng J; Zhang C; Ma K; Zhou C
    Arthritis Rheum; 2009 Sep; 60(9):2714-22. PubMed ID: 19714632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyul-Tong-Ryung suppresses PMA-induced MMP-9 expression by inhibiting AP-1-mediated gene expression via ERK 1/2 signaling pathway in MCF-7 human breast cancer cells.
    Kim KS; Yao L; Lee YC; Chung E; Kim KM; Kwak YJ; Kim SJ; Cui Z; Lee JH
    Immunopharmacol Immunotoxicol; 2010 Dec; 32(4):600-6. PubMed ID: 20131957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The novel synthesized 6-fluoro-(3-fluorophenyl)-4-(3-methoxyanilino)quinazoline (LJJ-10) compound exhibits anti-metastatic effects in human osteosarcoma U-2 OS cells through targeting insulin-like growth factor-I receptor.
    Chen KT; Hour MJ; Tsai SC; Chung JG; Kuo SC; Lu CC; Chiu YJ; Chuang YH; Yang JS
    Int J Oncol; 2011 Sep; 39(3):611-9. PubMed ID: 21667022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of autocrine TNF-alpha-stimulated matrix metalloproteinase 9 (MMP-9) expression by mitogen-activated protein kinases in THP-1 monocytic cells.
    Heidinger M; Kolb H; Krell HW; Jochum M; Ries C
    Biol Chem; 2006 Jan; 387(1):69-78. PubMed ID: 16497166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ornithine decarboxylase overexpression enhances ERK and p38 phosphorylation and matrix metalloproteinase-2 expression.
    Nemoto T; Kubota S
    Cell Biol Int; 2007 Feb; 31(2):141-7. PubMed ID: 17088079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidermal growth factor-induced matrix metalloproteinase-1 expression is negatively regulated by p38 MAPK in human skin fibroblasts.
    Park CH; Chung JH
    J Dermatol Sci; 2011 Nov; 64(2):134-41. PubMed ID: 21872446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-1beta induces MMP-9 expression via a Ca2+-dependent CaMKII/JNK/c-JUN cascade in rat brain astrocytes.
    Wu CY; Hsieh HL; Sun CC; Yang CM
    Glia; 2009 Dec; 57(16):1775-89. PubMed ID: 19455716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depsipeptide a histone deacetlyase inhibitor down regulates levels of matrix metalloproteinases 2 and 9 mRNA and protein expressions in lung cancer cells (A549).
    Vinodhkumar R; Song YS; Ravikumar V; Ramakrishnan G; Devaki T
    Chem Biol Interact; 2007 Feb; 165(3):220-9. PubMed ID: 17240363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of matrix metalloproteinase-2 in ethanol-induced invasion by breast cancer cells.
    Luo J
    J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S65-8. PubMed ID: 16958676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of p42/p44 MAPK, p38 MAPK, JNK and nuclear factor-kappa B in interleukin-1beta-induced matrix metalloproteinase-9 expression in rat brain astrocytes.
    Wu CY; Hsieh HL; Jou MJ; Yang CM
    J Neurochem; 2004 Sep; 90(6):1477-88. PubMed ID: 15341531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of mitogen-activated protein kinase on phorbol 12-myristate 13-acetate-induced matrix metalloproteinase-9 gene expression in cytotrophoblastic cells].
    Zhang XQ; Huang LP; Zhao XS; Li H; Chen SL; Xing FQ
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Mar; 24(3):282-5. PubMed ID: 15041541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
    Farabegoli F; Papi A; Orlandi M
    Biosci Rep; 2011 Apr; 31(2):99-108. PubMed ID: 20446926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanical force enhances MMP-2 activation via p38 signaling pathway in human retinal pigment epithelial cells.
    Hou X; Han QH; Hu D; Tian L; Guo CM; Du HJ; Zhang P; Wang YS; Hui YN
    Graefes Arch Clin Exp Ophthalmol; 2009 Nov; 247(11):1477-86. PubMed ID: 19590887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MMP-2 mediates ethanol-induced invasion of mammary epithelial cells over-expressing ErbB2.
    Ke Z; Lin H; Fan Z; Cai TQ; Kaplan RA; Ma C; Bower KA; Shi X; Luo J
    Int J Cancer; 2006 Jul; 119(1):8-16. PubMed ID: 16450376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-1 beta promotes A549 cell migration via MAPKs/AP-1- and NF-kappaB-dependent matrix metalloproteinase-9 expression.
    Lin CC; Kuo CT; Cheng CY; Wu CY; Lee CW; Hsieh HL; Lee IT; Yang CM
    Cell Signal; 2009 Nov; 21(11):1652-62. PubMed ID: 19616091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of ERK signaling evokes autocrine Fas-mediated death in arachidonic acid-treated human chronic myeloid leukemia K562 cells.
    Chen KC; Liu WH; Chang LS
    J Cell Physiol; 2010 Mar; 222(3):625-34. PubMed ID: 19927299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laminin-induced signaling in tumor cells: the role of the M(r) 67,000 laminin receptor.
    Givant-Horwitz V; Davidson B; Reich R
    Cancer Res; 2004 May; 64(10):3572-9. PubMed ID: 15150114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aurothiomalate inhibits cyclooxygenase 2, matrix metalloproteinase 3, and interleukin-6 expression in chondrocytes by increasing MAPK phosphatase 1 expression and decreasing p38 phosphorylation: MAPK phosphatase 1 as a novel target for antirheumatic drugs.
    Nieminen R; Korhonen R; Moilanen T; Clark AR; Moilanen E
    Arthritis Rheum; 2010 Jun; 62(6):1650-9. PubMed ID: 20178133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.